Efficacy of Harpagophytum procumbens Extract in Osteoarthritis, Low Back Pain and Fibromyalgia: a Review of Researches
Journal Title: Біль. Суглоби. Хребет - Year 2014, Vol 3, Issue 15
Abstract
The review presents the results of studies on clinical efficacy of Harpagophytum procumbens in the treatment of musculoskeletal pain. Pharmacological effects of Harpagophytum procumbens are associated with the inhibition of formation and releasing of proinflammatory cytokines IL-1β, IL-6 and TNF-α from macrophages, inhibition of expression of cyclooxygenase type 2 (COX-2) and inducible NO-synthase (iNOS) in fibroblasts and inhibition of development of lipid peroxidation, all of which lead to the suppression of the inflammatory response and, as result, development of analgesic effect and chondroprotection. Clinical Application. In case of osteoarthritis Harpagophytum procumbens extract (Sustamar) reduced the severity of pain by an average of 25–50 % and increased joint mobility of about 35–50 %; in case of lumbar pain it reduced the severity of pain at 40–50 %, the pain completely disappeared in 2.5–20 % of patients; it was effective in generalized and localized forms of fibromyalgia. Usage of Harpagophytum procumbens extract in case of any musculoskeletal pain was associated with the fact that approximately 60 % of patients reduced the dose or completely stop taking non-steroidal and steroidal anti-inflammatory drugs. It is possible that the efficacy of Harpagophytum procumbens extract corresponds to that of a standard dose of rofecoxib 12.5 mg, however, these data need to be confirmed. Safety. When receiving Harpagophytum procumbens extract, mild side effects (mainly dyspeptic) occurred in approximately 3 % of patients that did not exceed the appropriate frequency occurring in patients receiving placebo. Long-term use of Harpagophytum procumbens extract (up to 1 year) is safe and not associated with the development of toxic effects. Patients’ adherence to the treatment was 96.4 %. The tolerability of Harpagophytum procumbens extract seems to exceed that of selective COX-2 inhibitors. Conclusions. Harpagophytum procumbens extract is an effective and safe agent for the treatment of musculoskeletal pain. For further study of this drug it is necessary to conduct larger studies of higher quality.
Authors and Affiliations
A. V. Savustyanenko
Keywords
Related Articles
- EP ID EP226518
- DOI -
- Views 93
- Downloads 0
Analysis of the effectiveness of conservative treatment of patients with low-back pain by regenerative injecting therapy
Background. An open-label clinical study was conducted to evaluate the efficacy and tolerability of regenerative injecting therapy. The purpose of the study: to assess the effectiveness of regenerative injecting therapy,...
Osteopoikilosis — Disease without Clinical Symptoms, or Albers-Schönberg Disease
The events in this clinical case should be considered in this way: unknown congenital heredity — road accident — radiography — osteopoikolosis.
Influence of Vitamin D Deficiency on Rheumatoid Arthritis Course
The article deals with the influence of vitamin D deficiency on the course of rheumatoid arthritis. It encloses the review and the results of own researches. It was found that 54.9 % of the patients with rheumatoid arthr...
IX International Conference of Young Scientists «Musculoskeletal Diseases and Age» Is Devoted to the Memory of Professor Ye.P. Podrushniak
The article is a review of the key highlights, which were in focus of the annual conference of young scientists «Musculoskeletal Diseases and Age». Short review of study results, which were provided by young scientists,...
Metabolic factors determining the effectiveness of hypouricemic treatment of gouty arthritis
Background. The treatment of some forms of articular pathology with gout remains insufficiently effective, and often it’s impossible to achieve normal indicators of uricemia on the background of uric acid-normalizing me...